|Bid||577.93 x 1100|
|Ask||578.48 x 1400|
|Day's range||576.06 - 583.27|
|52-week range||441.00 - 660.00|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||16.45|
|Earnings date||03 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||632.91|
Dr. Anand Swaminathan, Emergency Medicine Physician in New Jersey, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Everything that could go right for Moderna (NASDAQ: MRNA) seems to be going right. Could a meltdown be on the way for Moderna stock? There's no question that Moderna's valuation has reached lofty heights of late.
Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.